- In December 2023, Carl Zeiss Meditec AG announced an agreement to acquire 100% of the shares in D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. for approximately USD 1.09 billion. This significant acquisition is poised to bring transformative advancements to ZEISS Medical Technology's extensive ophthalmic portfolio, reinforcing its position in the rapidly growing ophthalmic surgical instruments market
- In August 2023, Johnson & Johnson Vision presented its ELITA laser correction device in the U.S. launch. This platform is revolutionary for correcting short-sightedness through a minimally invasive laser-assisted lens removal procedure. This advancement highlights Johnson & Johnson Vision's commitment to developing cutting-edge safety technologies that safeguard vulnerable spaces, ensuring greater protection and peace of mind for patients and institutions
- In July 2024, Alcon Research, LLC. received U.S. FDA approval for the UNIPURE C3F8 Ophthalmic Gas, a gas injected into the eye to treat uncomplicated retinal detachment. This gas uses the company's UNIFEYE or UNIPEXY Gas Delivery Systems and will be commercially available in 2025. This initiative highlights Alcon's dedication to utilizing its expertise in innovative surgical systems, contributing to the development of safer, more effective treatments for retinal conditions
- In May 2023, Bausch + Lomb Corp. reported the launch in the U.S. of an ophthalmic viscosurgical device (OVD) designed to protect patients during cataract surgery. This collaboration is designed to enhance safety and streamline procedures for ophthalmic professionals, facilitating more efficient and secure surgical transactions. The initiative underscores Bausch + Lomb's commitment to driving innovation and improving operational effectiveness within the ophthalmic surgical sector
- In March 2023, WaveFront Dynamics Inc. announced the commercial launch of its WaveDyn Vision Analyzer. This innovative diagnostic system is designed to enhance the precision of refractive surgery planning, offering a reliable and effective solution for optimizing patient outcomes. This advancement highlights WaveFront Dynamics' commitment to developing cutting-edge technologies that safeguard vision, ensuring greater precision and peace of mind for institutions and their patients
